Table 2.
Aggregated measures of the distributive effect of total OOPP and OOPP categories
| Total OOPP | Prescription fees | OTC pharmaceuticals | Therapeutical aids | Physician services | ||
|---|---|---|---|---|---|---|
| ATP I | ||||||
| Gini coefficient | 0.245 | - | - | - | - | - |
| Concentration index | - | 0.138 | 0.036 | 0.089 | 0.162 | 0.152 |
| Kakwani index | - | −0.107 | −0.209 | −0.156 | −0.083 | −0.092 |
| t = OOPP/ATP I | 0.054 | 0.004 | 0.006 | 0.023 | 0.014 | |
| Reynolds–Smolensky index | - | −0.006 | −0.001 | −0.001 | −0.002 | −0.001 |
| ATP II | ||||||
| Gini coefficient | 0.538 | - | - | - | - | - |
| Concentration index | - | 0.093 | 0.044 | 0.045 | 0.109 | 0.086 |
| Kakwani index | - | −0.445 | −0.494 | −0.492 | −0.429 | −0.452 |
| t = OOPP/ATP II | - | 0.121 | 0.008 | 0.013 | 0.052 | 0.031 |
| Reynolds–Smolensky index | - | −0.061 | −0.004 | −0.006 | −0.024 | −0.015 |
ATP I ability to pay indicated by household net income, ATP II ability to pay indicated by household net income minus benefits from the income maintenance program, OOPP out-of-pocket payment, OTC over the counter, t share of OOPP on ATP I respectively ATP II